GW Pharmaceuticals EV/EBIT
Что обозначает EV/EBIT в GW Pharmaceuticals?
EV/EBIT GW Pharmaceuticals является N/A
Какое определение для EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT компаний в Health Care сектор на NASDAQ по сравнению с GW Pharmaceuticals
Компании с ev/ebit похож на GW Pharmaceuticals
- Alberton Acquisition имеет EV/EBIT из N/A
- Sigma Lithium Resources имеет EV/EBIT из N/A
- Berkshire Hathaway имеет EV/EBIT из N/A
- Mukand имеет EV/EBIT из N/A
- Prajay Engineers Syndicate имеет EV/EBIT из N/A
- Everest Consolidator Acquisition имеет EV/EBIT из N/A
- GW Pharmaceuticals имеет EV/EBIT из N/A
- 88 имеет EV/EBIT из N/A
- Confederation Minerals имеет EV/EBIT из N/A
- MongoDB Inc имеет EV/EBIT из N/A
- Development имеет EV/EBIT из N/A
- Oi S.A имеет EV/EBIT из N/A
- American Superconductor имеет EV/EBIT из N/A